Spine Injury Solutions, Inc. (OTCMKTS:SPIN - Get Free Report)'s share price passed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $31.54 and traded as high as $31.61. Spine Injury Solutions shares last traded at $31.56, with a volume of 3,612 shares changing hands.
Spine Injury Solutions Price Performance
The stock has a fifty day moving average price of $31.51 and a two-hundred day moving average price of $25.38. The company has a market cap of $16.32 billion and a P/E ratio of -344.06.
Spine Injury Solutions Dividend Announcement
The business also recently announced a dividend, which was paid on Wednesday, February 5th. Stockholders of record on Monday, February 3rd were issued a $0.1574 dividend. The ex-dividend date was Monday, February 3rd. Spine Injury Solutions's dividend payout ratio is presently -953.32%.
About Spine Injury Solutions
(
Get Free Report)
Spine Injury Solutions, Inc provides a suite of revolutionary electrical power generation technologies. The company intends to offer Evirontek Integrated Platform to the cryptocurrency mining industry to reduce the exorbitant high cost of electricity. It also provides spine injury diagnostic services; and owns, develops, and leases the Quad Video Halo video recording system used to record medical procedures.
Featured Stories
Before you consider Spine Injury Solutions, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spine Injury Solutions wasn't on the list.
While Spine Injury Solutions currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
